office location

301

office phone

e-mail

caoxia@jlu.edu.cn

educational background

In 1994, graduated from Bethune Medical University majoring in medicine ; In 1999, received a master's degree in pharmacology from Bethune Medical University; In 2004, obtained a doctorate degree in biochemistry and molecular biology from Jilin University ；From 2004 to 2007, obtained a postdoctoral degree in Medical Bioengineering.

occupational history

In 1994, Bethune Medical University School of Basic Medicine; In 1999, promoted to lecturer; From 2002 to now, worked at the School of Pharmacy of Jilin University; In 2004, promoted to associate professor; In 2011, promoted to professor;In 2012, appointed as the doctoral supervisor of Jilin University.

teaching courses

Pharmacology, Clinical pharmacotherapy

research field

Cardiovascular pharmacology

scientific payoffs

Chief editor of the “13th five-year ” and the “ 14th five-year ” planning textbooks 《Clinical Pharmacotherapy》for pharmaceutical majors in general medical colleges and universities Academic achievements: 1. Xiaohua Li, Peng Liu, Zhiping Xu,Dong Sun,Jingkai Gu,Yujia Miao,Jujin Zhang, Xia Cao. A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y12 Receptor. Cardiovascular Drugs and Therapy 2020,34(1):15–23. * Corresponding author

2.Na Du, Shunan Liu, Chongshuang Cui, Fang Hao, Mingyue Gao, Zhiping Xu and Xia Cao. Yishenhuoxue formula regulates TGF-β/Smad signal transduction to protect rats against Diabetic kidney disease injury. Pakistan Journal of Pharmaceutical Sciences, 2020,33(1):21-26* Corresponding author

3.Zhiping Xu, Jingkai Gu, Mingyue Gao, Na Du, Peng liu, Xueyu Xu, Jiayu Wang, Xia Cao. Study on antiplatelet effect of a new thiophenopyridine platelets P2Y12 receptor antagonist DV-127. Thrombosis Research, 2018, 170(10):192-199. * Corresponding author

4.Na Du, Zhiping Xu, Mingyue Gao, Peng Liu, Bo Sun, Xia Cao. Combination of Ginsenoside Rg1 and . Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. Drug Design, Development and Therapy. 2018, 12:3517–3524. * Corresponding author

5.Na Du, Shunan Liu, Chongshuang Cui, Mo Zhang, Jibin Jia and Xia Cao*. DMP-1 Attenuates Oxidative Stress and Inhibits TGF-β Activation in Rats with Diabetic Kidney Disease.RENAL FAILURE, 2017;39(1):229-235. * Corresponding author

6.Xue-mei Han, Hong-ji Tian, Zheng Han, Ce Zhang, Ying Liu, Jie-bing Gu, Rohit Bakshi, Xia Cao*.Correlation between white matter damage and gray matter lesions in multiple sclerosis patients. NEURAL REGENERATION RESEARCH. 2017;12(5):787-794. *Corresponding author

7.Qian Yu, Xin Li, Xia Cao*. Linarin could protect myocardial tissue from the injury of Ischemia-reperfusion through activating Nrf-2. Biomedicine & Pharmacotherapy. 2017;90(6):1-7. * Corresponding author

8.Qian Yu, Xin Li, Xia Cao*. Cardioprotective effects of Phenylethanoid Glycoside-Rich Extract from Cistanche deserticola in ischemia-reperfusion induced myocardial infarction in rats. Annals of Vascular Surgery. 2016;34(7): 234-242. * Corresponding author

9. Cao X, Fang L, Cui CY, Gao S, Wang TW. DTI and pathological changes in a rabbit model of radiation injury to the spinal cord after 125I radioactive seed implantation. Neural Regen Res. 2018;13(3):528-535.